INTEGRA LIFESCIENCES HOLDINGS CORP Increase (Decrease) in Contract with Customer, Liability
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) reported Increase (Decrease) in Contract with Customer, Liability of -$1.39 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-07-29
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$762.00K, a 136.29% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$630.00K, a 358.20% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was $685.00K, a 60.13% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $371.00K.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in contract with customer, liability for fiscal 2025 was $3.40M, a 3.95% decline from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in contract with customer, liability for fiscal 2024 was $3.54M, a 2665.63% increase from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in contract with customer, liability for fiscal 2023 was $128.00K, a 97.01% decline from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP increase (decrease) in contract with customer, liability for fiscal 2022 was $4.27M, a 15164.29% increase from fiscal 2021.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$762.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$1.39M 10-Q · filed 2026-07-29 | -$707.00K derived: sum of 3 quarters · filed 2026-07-29 | -$336.00K derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$630.00K 10-Q · filed 2026-05-05 | $55.00K derived: sum of 2 quarters · filed 2026-05-05 | $426.00K derived: sum of 3 quarters · filed 2026-05-05 | $2.53M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $685.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.06M derived: sum of 2 quarters · filed 2026-02-26 | $3.16M derived: sum of 3 quarters · filed 2026-07-29 | $3.40M 10-K · filed 2026-02-26 |
| 2025-09-30 | $371.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $2.47M derived: sum of 2 quarters · filed 2026-07-29 | $2.71M 10-Q · filed 2025-10-30 | $4.43M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $2.34M 10-Q · filed 2026-07-29 | $4.06M derived: sum of 3 quarters · filed 2026-07-29 | $3.71M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | $244.00K 10-Q · filed 2026-05-05 | $1.96M derived: sum of 2 quarters · filed 2026-05-05 | $1.61M derived: sum of 3 quarters · filed 2026-05-05 | $5.28M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.37M derived: sum of 2 quarters · filed 2026-02-26 | $5.04M derived: sum of 3 quarters · filed 2026-02-26 | $3.54M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$347.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.32M derived: sum of 2 quarters · filed 2025-10-30 | $1.82M 10-Q · filed 2025-10-30 | $1.81M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $3.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $2.17M 10-Q · filed 2025-07-31 | $2.16M derived: sum of 3 quarters · filed 2026-02-26 | $1.57M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | -$1.50M 10-Q · filed 2025-05-05 | -$1.51M derived: sum of 2 quarters · filed 2026-02-26 | -$2.09M derived: sum of 3 quarters · filed 2026-02-26 | -$1.80M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$596.00K derived: sum of 2 quarters · filed 2026-02-26 | -$302.00K derived: sum of 3 quarters · filed 2026-02-26 | $128.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | -$583.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | -$289.00K derived: sum of 2 quarters · filed 2024-11-04 | $141.00K 10-Q · filed 2024-11-04 | $1.89M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $294.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29 | $724.00K 10-Q · filed 2024-07-29 | $2.47M derived: sum of 3 quarters · filed 2025-02-25 | $4.22M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $430.00K 10-Q · filed 2024-05-06 | $2.18M derived: sum of 2 quarters · filed 2025-02-25 | $3.93M derived: sum of 3 quarters · filed 2025-02-25 | $4.70M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $3.50M derived: sum of 2 quarters · filed 2025-02-25 | $4.27M derived: sum of 3 quarters · filed 2025-02-25 | $4.27M 10-K · filed 2025-02-25 |
| 2022-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $2.52M derived: sum of 2 quarters · filed 2023-10-25 | $2.52M 10-Q · filed 2023-10-25 | $2.55M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $774.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $774.00K 10-Q · filed 2023-07-27 | $802.00K derived: sum of 3 quarters · filed 2024-02-28 | $802.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $0.00 10-Q · filed 2022-04-27 | $28.00K derived: sum of 2 quarters · filed 2024-02-28 | $28.00K derived: sum of 3 quarters · filed 2024-02-28 | $111.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $28.00K derived: sum of 2 quarters · filed 2024-02-28 | $111.00K derived: sum of 3 quarters · filed 2024-02-28 | $28.00K 10-K · filed 2024-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | $83.00K derived: sum of 2 quarters · filed 2022-10-26 | $0.00 10-Q · filed 2022-10-26 | $511.00K derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $0.00 10-Q · filed 2022-07-27 | $511.00K derived: sum of 3 quarters · filed 2023-02-22 | $600.00K derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | -$83.00K 10-Q · filed 2022-04-27 | $428.00K derived: sum of 2 quarters · filed 2023-02-22 | $517.00K derived: sum of 3 quarters · filed 2023-02-22 | -$458.00K derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $511.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $600.00K derived: sum of 2 quarters · filed 2023-02-22 | -$375.00K derived: sum of 3 quarters · filed 2023-02-22 | -$37.00K 10-K · filed 2023-02-22 |
| 2020-09-30 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$886.00K derived: sum of 2 quarters · filed 2021-11-02 | -$548.00K 10-Q · filed 2021-11-02 | $240.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$975.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$637.00K 10-Q · filed 2020-08-10 | $151.00K derived: sum of 3 quarters · filed 2022-02-24 | $727.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $338.00K 10-Q · filed 2021-04-29 | $1.13M derived: sum of 2 quarters · filed 2022-02-24 | $1.70M derived: sum of 3 quarters · filed 2022-02-24 | -$81.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $788.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $1.36M derived: sum of 2 quarters · filed 2022-02-24 | -$419.00K derived: sum of 3 quarters · filed 2022-02-24 | -$607.00K 10-K · filed 2022-02-24 |
| 2019-09-30 | $576.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$1.21M derived: sum of 2 quarters · filed 2020-10-29 | -$1.40M 10-Q · filed 2020-10-29 | $220.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | -$1.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$1.97M 10-Q · filed 2020-08-10 | -$356.00K derived: sum of 3 quarters · filed 2021-02-23 | -$376.00K derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | -$188.00K 10-Q · filed 2020-05-07 | $1.43M derived: sum of 2 quarters · filed 2021-02-23 | $1.41M derived: sum of 3 quarters · filed 2021-02-23 | $1.32M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $1.61M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $1.59M derived: sum of 2 quarters · filed 2021-02-23 | $1.50M derived: sum of 3 quarters · filed 2021-02-23 | $1.50M 10-K · filed 2021-02-23 |
| 2018-09-30 | -$20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25 | -$111.00K derived: sum of 2 quarters · filed 2019-10-25 | -$111.00K 10-Q · filed 2019-10-25 | $2.36M derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | -$91.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-25 | -$91.00K 10-Q · filed 2019-07-25 | $2.38M derived: sum of 3 quarters · filed 2020-02-21 | |
| 2018-03-31 | $0.00 10-Q · filed 2019-04-29 | $2.47M derived: sum of 2 quarters · filed 2020-02-21 | ||
| 2017-12-31 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | $3.87M 10-K · filed 2020-02-21 | ||
| 2017-09-30 | $1.41M 10-Q · filed 2018-11-01 | |||
| 2016-12-31 | $1.25M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |